ProShare Advisors LLC - SYNDAX PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$190,241
-30.2%
13,102
+0.6%
0.00%0.0%
Q2 2023$272,549
+9.1%
13,022
+10.1%
0.00%0.0%
Q1 2023$249,765
-17.0%
11,826
-0.0%
0.00%0.0%
Q4 2022$300,997
+18.0%
11,827
+11.3%
0.00%0.0%
Q3 2022$255,000
+30.8%
10,626
+4.2%
0.00%0.0%
Q2 2022$195,000
-23.2%
10,193
-30.4%
0.00%0.0%
Q1 2022$254,000
-30.8%
14,636
-12.8%
0.00%0.0%
Q4 2021$367,000
+18.8%
16,785
+3.9%
0.00%0.0%
Q3 2021$309,000
-11.5%
16,151
-20.6%
0.00%0.0%
Q2 2021$349,000
+5.1%
20,334
+36.9%
0.00%0.0%
Q1 2021$332,000
+21.6%
14,856
+21.0%
0.00%0.0%
Q4 2020$273,000
+200.0%
12,275
+9.2%
0.00%0.0%
Q3 2018$91,000
+4.6%
11,240
-8.9%
0.00%0.0%
Q2 2018$87,000
-52.2%
12,337
-3.5%
0.00%0.0%
Q1 2018$182,000
+40.0%
12,782
-14.1%
0.00%0.0%
Q4 2017$130,000–14,887–0.00%–
 Download
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,600,000$52,272,0008.55%
Foresite Capital Management IV, LLC 875,000$12,705,0007.06%
Aisling Capital Management LP 1,025,000$14,883,0006.13%
Saturn V Capital Management LP 807,969$11,731,7104.91%
Eversept Partners, LP 2,596,245$37,697,4773.19%
ACUTA CAPITAL PARTNERS, LLC 297,035$4,312,9482.89%
Paradigm Biocapital Advisors LP 2,390,077$34,703,9182.36%
DAFNA Capital Management LLC 458,373$6,655,5762.07%
SPHERA FUNDS MANAGEMENT LTD. 773,061$11,224,8462.04%
PFM Health Sciences, LP 2,715,235$39,425,2121.86%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders